Chengping Li
Impact in
-
- Rabies epidemiology and control
Papers in
-
- Bioactive Natural Diterpenoids Research 5
- RNA Research and Splicing 4
- CRISPR and Genetic Engineering 4
- Cell death mechanisms and regulation 3
- PI3K/AKT/mTOR signaling in cancer 2
-
- Sesquiterpenes and Asteraceae Studies 3
- MicroRNA in disease regulation 3
- Co-authors
- Myeong‐Sok Lee (8 shared papers)Samil Jung (8 shared papers)Wei‐Guang Shan (5 shared papers)Zha‐Jun Zhan (5 shared papers)Yan Guo (4 shared papers)Jong‐Seok Lim (6 shared papers)Young Duk Yang (6 shared papers)Keun‐il Kim (5 shared papers)
- Journals
- International Journal of Oncology (4 papers)Oncotarget (2 papers)Bioscience Biotechnology and Biochemistry (2 papers)Journal of Agricultural and Food Chemistry (2 papers)Journal of Pharmaceutical Analysis (1 paper)
- Partner nations
- ChinaSouth KoreaFrance
In The Last Decade
Chengping Li
40 papers receiving 540 citations
Peers
Comparison fields: 5 of 61
- Virology 22
- Cancer Research 60
- Molecular Biology 280
- Hematology 20
- Epidemiology 41
Countries citing papers authored by Chengping Li
This map shows the geographic impact of Chengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengping Li more than expected).
Fields of papers citing papers by Chengping Li
This network shows the impact of papers produced by Chengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengping Li. The network helps show where Chengping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 53 | |
| 2 | 2023 | 51 | |
| 3 | 2022 | 49 | |
| 4 | 2021 | 35 | |
| 5 | 2024 | 31 | |
| 6 | 2021 | 25 | |
| 7 | 2018 | 24 | |
| 8 | 2015 | 23 | |
| 9 | 2007 | 22 | |
| 10 | 2009 | 16 | |
| 11 | 2011 | 16 | |
| 12 | 2015 | 16 | |
| 13 | 2012 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2009 | 12 | |
| 16 | 2014 | 12 | |
| 17 | 2021 | 12 | |
| 18 | 2015 | 10 | |
| 19 | 2019 | 10 | |
| 20 | 2023 | 10 |
About Chengping Li
Chengping Li is a scholar working on Molecular Biology, Cancer Research, Hematology, Oncology and Hepatology, having authored 43 papers that have together received 554 indexed citations. Recurring topics across this work include Bioactive Natural Diterpenoids Research (5 papers), RNA Research and Splicing (4 papers), CRISPR and Genetic Engineering (4 papers), Sesquiterpenes and Asteraceae Studies (3 papers), MicroRNA in disease regulation (3 papers), Cell death mechanisms and regulation (3 papers), Acute Myeloid Leukemia Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Virology (22 citations), Cancer Research (60 citations), Molecular Biology (280 citations), Hematology (20 citations) and Epidemiology (41 citations). Chengping Li has collaborated with scholars based in China, South Korea and France. Frequent co-authors include Myeong‐Sok Lee, Samil Jung, Wei‐Guang Shan, Zha‐Jun Zhan, Yan Guo, Jong‐Seok Lim, Young Duk Yang, Keun‐il Kim, Jiyeon Ohk and Guoli Zhou. Their work appears in journals such as International Journal of Oncology, Oncotarget, Bioscience Biotechnology and Biochemistry, Journal of Agricultural and Food Chemistry and Journal of Pharmaceutical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.